Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion type Assertion NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_head.
- NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion description "[From 1990 through 2000, urologic measures of BPH were assessed biennially from lower urinary tract symptom severity, peak flow rates, prostate volume, serum prostate specific antigen (PSA) level, acute urinary retention, and treatment for BPH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_provenance.
- NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion evidence source_evidence_literature NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_provenance.
- NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion SIO_000772 16302261 NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_provenance.
- NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion wasDerivedFrom befree-20140225 NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_provenance.
- NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_assertion wasGeneratedBy ECO_0000203 NP882197.RAXuod2nn4tOPyhG2fOYIUjtUM1f5gevnZ-6fayUK7FMw130_provenance.